Category:

25 October 2021

PHARMANUTRA S.P.A.: ALESCO SUBSIDIARY OBTAINS PATENT FOR THE NEW SUCROSOMIAL® BERBERINE

21 October 2021

PHARMANUTRA S.P.A. OBTAINS THE GRANT OF CETILAR® PROCESS PATENT IN INDIA

13 October 2021

NEW DISTRIBUTION AGREEMENTS WITH AMERICAN TAIWAN BIOPHARM CO. AND ARGON DRUG STORE

04 October 2021

PHARMANUTRA S.P.A. CONFIRMS GROWTH TREND IN ITALY AND STRONG RECOVERY ON INTERNATIONAL MARKETS

13 September 2021

HALF-YEAR FINANCIAL REPORT AS OF 30 JUNE 2021

06 September 2021

BOD APPROVED THE FIRST HALF FINANCIAL REPORT AS AT 30 JUNE 2021

25 August 2021

PHARMANUTRA S.P.A. OBTAINS THE GRANT OF CETILAR® PATENT IN CHINA

21 July 2021

EFSA IN FAVOUR OF AUTHORISING LIPOCET (CETILAR®) AS A NOVEL FOOD

29 June 2021

BOD approves the new Procedure relating to transactions with related parties

10 June 2021

AGREEMENT FOR THE DISTRIBUTION OF SIDERAL® IN GERMANY SIGNED WITH FRESENIUS KABI

07 June 2021

SALES FIGURES FOR MAY 2021: OVER 300,000 UNITS PER MONTH SOLD

26 May 2021

Publication of Shareholders’ Meetings minutes 26/04/2021

10 May 2021

PHARMANUTRA S.P.A.: BOARD APPROVES INTERIM MANAGEMENT REPORT AS OF 31ˢᵗ MARCH 2021

03 May 2021

PHARMANUTRA S.P.A.: ITALIAN MARKET DOUBLE FIGURE GROWTH ONCE AGAIN

29 April 2021

SYNTHETIC REPORT ON VOTING RESULTS OF THE ORDINARY SHAREHOLDERS’ MEETINGS HELD ON APRIL 26th 2021

26 April 2021

PHARMANUTRA S.P.A.: ORDINARY SHAREHOLDERS’ MEETING OF 26ᵗʰ APRIL 2021

19 April 2021

PHARMANUTRA S.P.A. LAUNCHES ITS NEW SIDERAL® MED

07 April 2021

A NEW STUDY DEMONSTRATES THE EFFECTS OF USING APPORTAL® IN PATIENTS SUFFERING FROM CHRONIC COVID SYNDROME

01 April 2021

FILING OF THE REPORT ON THE REMUNERATION POLICY

31 March 2021

NEW FILING OF DOCUMENTS FOR THE SHAREHOLDERS’ MEETING

25 March 2021

FILING OF DOCUMENTS FOR THE SHAREHOLDERS’ MEETING

< 1 … 4 5 6 … 11 >